[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fgKO3zyBWjR4-JSxsXhe1nHo4A-o9eWPFJTDSE1h5DBc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":47,"rows":54},"Erasme University Hospital",[4],177,false,23,5,92066,4,136,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"Anesthesia",10,{"name":18,"count":9},"Surgery",{"name":20,"count":9},"Obesity",{"name":22,"count":11},"Hemodynamic Instability",{"name":24,"count":11},"Healthy",{"name":26,"count":11},"Technology",{"name":28,"count":11},"Alcoholic Liver Disease",{"name":30,"count":31},"Closed-Loop Communication",3,[33,38,43],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT07532733","Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure","2027-05-30","Sedation with dexmedetomidine",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05004610","Hypertonic Lactate After Cardiac Arrest","2027-12-31","Sodium Lactate Solution",{"nctId":44,"briefTitle":45,"date":41,"intervention":46},"NCT05083247","Preoperative mFOLFIRINOX (or Gem-Nab-P) +\u002F- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma","mFOLFIRINOX or Gemcitabine nab-paclitaxel",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,82,106,129,147,187,215,233,260,287,305,330,357,386,410,440,469,487,512,538,556,581,605,632,650,677,695,721,747,765,783,831,865,887,909,949,971,998,1023,1047,1074,1103,1129,1147,1165,1191,1209,1227,1253,1280,1298,1316,1334,1359,1377,1404,1429,1457],{"intervention":42,"totalTrials":56,"cells":57},1,{"EARLY_PHASE1":58,"PHASE1":61,"PHASE2":63,"PHASE3":76,"PHASE4":78,"NA":80},{"trials":59,"activeCount":60},[],0,{"trials":62,"activeCount":60},[],{"trials":64,"activeCount":56,"soonestReadout":41},[65],{"nctId":39,"briefTitle":40,"status":66,"phases":67,"primaryCompletion":41,"completion":68,"start":69,"enrollment":70,"conditions":71,"interventions":75},"RECRUITING",[50],"2028-05-15","2025-02-19",125,[72,73,74],"Cardiac Arrest","Ischemia Reperfusion Injury","Anoxic Brain Injury",[42],{"trials":77,"activeCount":60},[],{"trials":79,"activeCount":60},[],{"trials":81,"activeCount":60},[],{"intervention":46,"totalTrials":56,"cells":83},{"EARLY_PHASE1":84,"PHASE1":86,"PHASE2":88,"PHASE3":100,"PHASE4":102,"NA":104},{"trials":85,"activeCount":60},[],{"trials":87,"activeCount":60},[],{"trials":89,"activeCount":56,"soonestReadout":41},[90],{"nctId":44,"briefTitle":45,"status":66,"phases":91,"primaryCompletion":41,"completion":92,"start":93,"enrollment":94,"conditions":95,"interventions":99},[50],"2030-12-31","2023-03-24",256,[96,97,98],"Pancreatic Neoplasm","Pancreatic Adenocarcinoma","Borderline Resectable Pancreatic Adenocarcinoma",[46],{"trials":101,"activeCount":60},[],{"trials":103,"activeCount":60},[],{"trials":105,"activeCount":60},[],{"intervention":37,"totalTrials":56,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":114,"PHASE4":116,"NA":118},{"trials":109,"activeCount":60},[],{"trials":111,"activeCount":60},[],{"trials":113,"activeCount":60},[],{"trials":115,"activeCount":60},[],{"trials":117,"activeCount":60},[],{"trials":119,"activeCount":56,"soonestReadout":36},[120],{"nctId":34,"briefTitle":35,"status":66,"phases":121,"primaryCompletion":36,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},[53],"2027-06-30","2026-04-22",80,[126],"TAVI(Transcatheter Aortic Valve Implantation)",[37,128],"sedation propofol and remifentanil",{"intervention":128,"totalTrials":56,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":141},{"trials":132,"activeCount":60},[],{"trials":134,"activeCount":60},[],{"trials":136,"activeCount":60},[],{"trials":138,"activeCount":60},[],{"trials":140,"activeCount":60},[],{"trials":142,"activeCount":56,"soonestReadout":36},[143],{"nctId":34,"briefTitle":35,"status":66,"phases":144,"primaryCompletion":36,"completion":122,"start":123,"enrollment":124,"conditions":145,"interventions":146},[53],[126],[37,128],{"intervention":148,"totalTrials":149,"cells":150},"Letrozole",2,{"EARLY_PHASE1":151,"PHASE1":153,"PHASE2":155,"PHASE3":157,"PHASE4":159,"NA":185},{"trials":152,"activeCount":60},[],{"trials":154,"activeCount":60},[],{"trials":156,"activeCount":60},[],{"trials":158,"activeCount":60},[],{"trials":160,"activeCount":60},[161,172],{"nctId":162,"briefTitle":163,"status":164,"phases":165,"primaryCompletion":166,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":171},"NCT04289805","Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)","TERMINATED",[52],"2025-01-15","2019-02-25",96,[170],"Breast Neoplasm Malignant Female",[148],{"nctId":173,"briefTitle":174,"status":175,"phases":176,"primaryCompletion":177,"completion":178,"start":179,"enrollment":180,"conditions":181,"interventions":184},"NCT02661932","Fertility Preservation in Breast Cancer Patients","COMPLETED",[52],"2018-03","2024-12","2012-11",65,[182,183],"Breast Neoplasms","Fertility",[148],{"trials":186,"activeCount":60},[],{"intervention":188,"totalTrials":56,"cells":189},"midazolam",{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":213},{"trials":191,"activeCount":60},[],{"trials":193,"activeCount":60},[],{"trials":195,"activeCount":60},[],{"trials":197,"activeCount":60},[],{"trials":199,"activeCount":60},[200],{"nctId":201,"briefTitle":202,"status":175,"phases":203,"primaryCompletion":204,"completion":204,"start":205,"enrollment":206,"conditions":207,"interventions":211},"NCT00596414","Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial",[52],"2005-10","2003-05",180,[208,209,210],"Cirrhosis","Chronic Hepatitis","Anxiety",[188,212],"midazolam + pethidine",{"trials":214,"activeCount":60},[],{"intervention":212,"totalTrials":56,"cells":216},{"EARLY_PHASE1":217,"PHASE1":219,"PHASE2":221,"PHASE3":223,"PHASE4":225,"NA":231},{"trials":218,"activeCount":60},[],{"trials":220,"activeCount":60},[],{"trials":222,"activeCount":60},[],{"trials":224,"activeCount":60},[],{"trials":226,"activeCount":60},[227],{"nctId":201,"briefTitle":202,"status":175,"phases":228,"primaryCompletion":204,"completion":204,"start":205,"enrollment":206,"conditions":229,"interventions":230},[52],[208,209,210],[188,212],{"trials":232,"activeCount":60},[],{"intervention":234,"totalTrials":56,"cells":235},"Caspofungin 70 mg",{"EARLY_PHASE1":236,"PHASE1":238,"PHASE2":240,"PHASE3":242,"PHASE4":244,"NA":258},{"trials":237,"activeCount":60},[],{"trials":239,"activeCount":60},[],{"trials":241,"activeCount":60},[],{"trials":243,"activeCount":60},[],{"trials":245,"activeCount":60},[246],{"nctId":247,"briefTitle":248,"status":175,"phases":249,"primaryCompletion":250,"completion":251,"start":252,"enrollment":253,"conditions":254,"interventions":257},"NCT01968395","Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure",[52],"2014-08","2014-10-21","2013-09",20,[255,256],"Bacterial Infections and Mycoses","Liver Disease",[234],{"trials":259,"activeCount":60},[],{"intervention":261,"totalTrials":56,"cells":262},"Remifentanil adapted to SPI",{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":285},{"trials":264,"activeCount":60},[],{"trials":266,"activeCount":60},[],{"trials":268,"activeCount":60},[],{"trials":270,"activeCount":60},[],{"trials":272,"activeCount":60},[273],{"nctId":274,"briefTitle":275,"status":175,"phases":276,"primaryCompletion":277,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":283},"NCT02884310","Interest of a Tetanus Test at a Fixed Remifentanil Concentration Before Laryngoscopy and Skin Incision",[52],"2014-12","2016-05","2013-01",48,[282],"Intravenous Anesthetic Agent Overdose",[261,284],"Remifentanil fixed",{"trials":286,"activeCount":60},[],{"intervention":284,"totalTrials":56,"cells":288},{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":297,"NA":303},{"trials":290,"activeCount":60},[],{"trials":292,"activeCount":60},[],{"trials":294,"activeCount":60},[],{"trials":296,"activeCount":60},[],{"trials":298,"activeCount":60},[299],{"nctId":274,"briefTitle":275,"status":175,"phases":300,"primaryCompletion":277,"completion":278,"start":279,"enrollment":280,"conditions":301,"interventions":302},[52],[282],[261,284],{"trials":304,"activeCount":60},[],{"intervention":306,"totalTrials":56,"cells":307},"Sugammadex Injection [Bridion]",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":328},{"trials":309,"activeCount":60},[],{"trials":311,"activeCount":60},[],{"trials":313,"activeCount":60},[],{"trials":315,"activeCount":60},[],{"trials":317,"activeCount":60},[318],{"nctId":319,"briefTitle":320,"status":175,"phases":321,"primaryCompletion":322,"completion":322,"start":323,"enrollment":324,"conditions":325,"interventions":327},"NCT03515694","Minimal Optimal Dose of Sugammadex in Elective Surgery",[52],"2018-09-30","2018-04-03",40,[326],"Time of a TOF Ratio >0,9",[306],{"trials":329,"activeCount":60},[],{"intervention":331,"totalTrials":56,"cells":332},"Influenza A\u002FH1N1 2009-AS03 adjuvanted",{"EARLY_PHASE1":333,"PHASE1":335,"PHASE2":337,"PHASE3":339,"PHASE4":341,"NA":355},{"trials":334,"activeCount":60},[],{"trials":336,"activeCount":60},[],{"trials":338,"activeCount":60},[],{"trials":340,"activeCount":60},[],{"trials":342,"activeCount":60},[343],{"nctId":344,"briefTitle":345,"status":175,"phases":346,"primaryCompletion":347,"completion":347,"start":348,"enrollment":349,"conditions":350,"interventions":354},"NCT01298102","Influenza A\u002FH1N1\u002F2009-adjuvanted Vaccine in Renal Disease Patients",[52],"2010-03","2009-10",185,[351,352,353],"Decreased Immunologic Activity [PE]","Influenza","Rejection",[331],{"trials":356,"activeCount":60},[],{"intervention":358,"totalTrials":56,"cells":359},"Clonidine",{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":368,"NA":384},{"trials":361,"activeCount":60},[],{"trials":363,"activeCount":60},[],{"trials":365,"activeCount":60},[],{"trials":367,"activeCount":60},[],{"trials":369,"activeCount":60},[370],{"nctId":371,"briefTitle":372,"status":373,"phases":374,"primaryCompletion":375,"completion":376,"start":377,"enrollment":378,"conditions":379,"interventions":382},"NCT04758936","Clonidine vs. Dexmedetomidine in Agitated Delirium in Intensive Care Patients","UNKNOWN",[52],"2022-02-28","2023-02-28","2021-02-01",50,[380,381],"Delirium","Critical Illness",[358,383],"Dexmedetomidine",{"trials":385,"activeCount":60},[],{"intervention":387,"totalTrials":56,"cells":388},"Solu-medrol or placebo administration",{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":408},{"trials":390,"activeCount":60},[],{"trials":392,"activeCount":60},[],{"trials":394,"activeCount":60},[],{"trials":396,"activeCount":60},[],{"trials":398,"activeCount":60},[399],{"nctId":400,"briefTitle":401,"status":164,"phases":402,"primaryCompletion":403,"completion":403,"start":278,"enrollment":324,"conditions":404,"interventions":407},"NCT02798068","Steroids and Microcirculation In Cardiac Surgery",[52],"2021-09",[405,406],"C.Surgical Procedure","Cardiac",[387],{"trials":409,"activeCount":60},[],{"intervention":411,"totalTrials":56,"cells":412},"Angiotensin 1-7",{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":419,"PHASE4":436,"NA":438},{"trials":414,"activeCount":60},[],{"trials":416,"activeCount":60},[],{"trials":418,"activeCount":60},[],{"trials":420,"activeCount":60},[421],{"nctId":422,"briefTitle":423,"status":373,"phases":424,"primaryCompletion":425,"completion":426,"start":427,"enrollment":428,"conditions":429,"interventions":434},"NCT04332666","Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",[50,51],"2022-12-30","2023-06-15","2021-12-30",60,[430,431,432,433],"Coronavirus","Respiratory Failure","Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere","SARS-CoV-2",[411,435],"Placebos",{"trials":437,"activeCount":60},[],{"trials":439,"activeCount":60},[],{"intervention":441,"totalTrials":56,"cells":442},"Triptorelin",{"EARLY_PHASE1":443,"PHASE1":445,"PHASE2":447,"PHASE3":449,"PHASE4":465,"NA":467},{"trials":444,"activeCount":60},[],{"trials":446,"activeCount":60},[],{"trials":448,"activeCount":60},[],{"trials":450,"activeCount":60},[451],{"nctId":452,"briefTitle":453,"status":175,"phases":454,"primaryCompletion":455,"completion":456,"start":457,"enrollment":458,"conditions":459,"interventions":463},"NCT01160315","Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure",[50,51],"2010-06","2015-10","2002-07",118,[460,461,462],"Fertility Preservation","Alkylating Agents","Lymphoma",[441,464],"Norethisterone acetate",{"trials":466,"activeCount":60},[],{"trials":468,"activeCount":60},[],{"intervention":464,"totalTrials":56,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":477,"PHASE4":483,"NA":485},{"trials":472,"activeCount":60},[],{"trials":474,"activeCount":60},[],{"trials":476,"activeCount":60},[],{"trials":478,"activeCount":60},[479],{"nctId":452,"briefTitle":453,"status":175,"phases":480,"primaryCompletion":455,"completion":456,"start":457,"enrollment":458,"conditions":481,"interventions":482},[50,51],[460,461,462],[441,464],{"trials":484,"activeCount":60},[],{"trials":486,"activeCount":60},[],{"intervention":488,"totalTrials":56,"cells":489},"N-Acetylcysteine",{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":496,"PHASE4":508,"NA":510},{"trials":491,"activeCount":60},[],{"trials":493,"activeCount":60},[],{"trials":495,"activeCount":60},[],{"trials":497,"activeCount":60},[498],{"nctId":499,"briefTitle":500,"status":175,"phases":501,"primaryCompletion":502,"start":503,"enrollment":504,"conditions":505,"interventions":507},"NCT00962442","N-Acetylcysteine in Severe Acute Alcoholic Hepatitis",[51],"2006-01","2000-09",44,[506],"Alcoholic Hepatitis",[488],{"trials":509,"activeCount":60},[],{"trials":511,"activeCount":60},[],{"intervention":513,"totalTrials":56,"cells":514},"LABA",{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":521,"PHASE4":534,"NA":536},{"trials":516,"activeCount":60},[],{"trials":518,"activeCount":60},[],{"trials":520,"activeCount":60},[],{"trials":522,"activeCount":60},[523],{"nctId":524,"briefTitle":525,"status":175,"phases":526,"primaryCompletion":527,"completion":527,"start":528,"enrollment":529,"conditions":530,"interventions":532},"NCT05927155","Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD",[51],"2022-03-30","2021-06-15",30,[531],"Pulmonary Disease, Chronic Obstructive",[513,533],"LAMA",{"trials":535,"activeCount":60},[],{"trials":537,"activeCount":60},[],{"intervention":533,"totalTrials":56,"cells":539},{"EARLY_PHASE1":540,"PHASE1":542,"PHASE2":544,"PHASE3":546,"PHASE4":552,"NA":554},{"trials":541,"activeCount":60},[],{"trials":543,"activeCount":60},[],{"trials":545,"activeCount":60},[],{"trials":547,"activeCount":60},[548],{"nctId":524,"briefTitle":525,"status":175,"phases":549,"primaryCompletion":527,"completion":527,"start":528,"enrollment":529,"conditions":550,"interventions":551},[51],[531],[513,533],{"trials":553,"activeCount":60},[],{"trials":555,"activeCount":60},[],{"intervention":557,"totalTrials":56,"cells":558},"Angiotensin-",{"EARLY_PHASE1":559,"PHASE1":561,"PHASE2":563,"PHASE3":575,"PHASE4":577,"NA":579},{"trials":560,"activeCount":60},[],{"trials":562,"activeCount":60},[],{"trials":564,"activeCount":60},[565],{"nctId":566,"briefTitle":567,"status":175,"phases":568,"primaryCompletion":569,"completion":569,"start":570,"enrollment":571,"conditions":572,"interventions":574},"NCT04633772","Use of Angiotensin-(1-7) in COVID-19",[49,50],"2021-11-01","2020-08-05",112,[573,431],"Infection, Coronavirus",[557],{"trials":576,"activeCount":60},[],{"trials":578,"activeCount":60},[],{"trials":580,"activeCount":60},[],{"intervention":582,"totalTrials":56,"cells":583},"PREOB® Intravenous",{"EARLY_PHASE1":584,"PHASE1":586,"PHASE2":588,"PHASE3":599,"PHASE4":601,"NA":603},{"trials":585,"activeCount":60},[],{"trials":587,"activeCount":60},[],{"trials":589,"activeCount":60},[590],{"nctId":591,"briefTitle":592,"status":175,"phases":593,"primaryCompletion":594,"completion":594,"start":595,"enrollment":253,"conditions":596,"interventions":598},"NCT02061995","Phase 2a Study on Intravenous Infusion of Autologous Osteoblastic Cells in Severe Osteoporosis",[50],"2016-10","2013-12",[597],"Severe Osteoporosis",[582],{"trials":600,"activeCount":60},[],{"trials":602,"activeCount":60},[],{"trials":604,"activeCount":60},[],{"intervention":606,"totalTrials":56,"cells":607},"Core decompression\u002FPREOB® implantation",{"EARLY_PHASE1":608,"PHASE1":610,"PHASE2":612,"PHASE3":626,"PHASE4":628,"NA":630},{"trials":609,"activeCount":60},[],{"trials":611,"activeCount":60},[],{"trials":613,"activeCount":60},[614],{"nctId":615,"briefTitle":616,"status":175,"phases":617,"primaryCompletion":618,"completion":619,"start":620,"enrollment":621,"conditions":622,"interventions":624},"NCT02890537","Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head",[50],"2011-05","2015-01","2003-10",82,[623],"Avascular Necrosis of Femur Head",[606,625],"Core decompression\u002FBMC implantation",{"trials":627,"activeCount":60},[],{"trials":629,"activeCount":60},[],{"trials":631,"activeCount":60},[],{"intervention":625,"totalTrials":56,"cells":633},{"EARLY_PHASE1":634,"PHASE1":636,"PHASE2":638,"PHASE3":644,"PHASE4":646,"NA":648},{"trials":635,"activeCount":60},[],{"trials":637,"activeCount":60},[],{"trials":639,"activeCount":60},[640],{"nctId":615,"briefTitle":616,"status":175,"phases":641,"primaryCompletion":618,"completion":619,"start":620,"enrollment":621,"conditions":642,"interventions":643},[50],[623],[606,625],{"trials":645,"activeCount":60},[],{"trials":647,"activeCount":60},[],{"trials":649,"activeCount":60},[],{"intervention":651,"totalTrials":56,"cells":652},"Regorafenib\u002Factive",{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":657,"PHASE3":671,"PHASE4":673,"NA":675},{"trials":654,"activeCount":60},[],{"trials":656,"activeCount":60},[],{"trials":658,"activeCount":60},[659],{"nctId":660,"briefTitle":661,"status":373,"phases":662,"primaryCompletion":663,"completion":664,"start":665,"enrollment":666,"conditions":667,"interventions":669},"NCT02162914","Regorafenib Versus Placebo to Treat Cholangiocarcinoma",[50],"2019-03","2020-12","2014-03-14",66,[668],"Cholangiocarcinoma",[651,670],"Regorafenib\u002Fplacebo",{"trials":672,"activeCount":60},[],{"trials":674,"activeCount":60},[],{"trials":676,"activeCount":60},[],{"intervention":670,"totalTrials":56,"cells":678},{"EARLY_PHASE1":679,"PHASE1":681,"PHASE2":683,"PHASE3":689,"PHASE4":691,"NA":693},{"trials":680,"activeCount":60},[],{"trials":682,"activeCount":60},[],{"trials":684,"activeCount":60},[685],{"nctId":660,"briefTitle":661,"status":373,"phases":686,"primaryCompletion":663,"completion":664,"start":665,"enrollment":666,"conditions":687,"interventions":688},[50],[668],[651,670],{"trials":690,"activeCount":60},[],{"trials":692,"activeCount":60},[],{"trials":694,"activeCount":60},[],{"intervention":696,"totalTrials":56,"cells":697},"Hemin",{"EARLY_PHASE1":698,"PHASE1":700,"PHASE2":702,"PHASE3":715,"PHASE4":717,"NA":719},{"trials":699,"activeCount":60},[],{"trials":701,"activeCount":60},[],{"trials":703,"activeCount":60},[704],{"nctId":705,"briefTitle":706,"status":175,"phases":707,"primaryCompletion":708,"completion":709,"start":710,"enrollment":711,"conditions":712,"interventions":714},"NCT01855841","Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis",[50],"2021-06-01","2021-06","2012-04",284,[713],"Post-ERCP Acute Pancreatitis",[696],{"trials":716,"activeCount":60},[],{"trials":718,"activeCount":60},[],{"trials":720,"activeCount":60},[],{"intervention":722,"totalTrials":56,"cells":723},"filgrastim",{"EARLY_PHASE1":724,"PHASE1":726,"PHASE2":728,"PHASE3":741,"PHASE4":743,"NA":745},{"trials":725,"activeCount":60},[],{"trials":727,"activeCount":60},[],{"trials":729,"activeCount":60},[730],{"nctId":731,"briefTitle":732,"status":373,"phases":733,"start":734,"enrollment":735,"conditions":736,"interventions":738},"NCT00526734","High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma",[50],"2006-02",100,[737],"Multiple Myeloma and Plasma Cell Neoplasm",[722,739,740],"pegfilgrastim","melphalan",{"trials":742,"activeCount":60},[],{"trials":744,"activeCount":60},[],{"trials":746,"activeCount":60},[],{"intervention":739,"totalTrials":56,"cells":748},{"EARLY_PHASE1":749,"PHASE1":751,"PHASE2":753,"PHASE3":759,"PHASE4":761,"NA":763},{"trials":750,"activeCount":60},[],{"trials":752,"activeCount":60},[],{"trials":754,"activeCount":60},[755],{"nctId":731,"briefTitle":732,"status":373,"phases":756,"start":734,"enrollment":735,"conditions":757,"interventions":758},[50],[737],[722,739,740],{"trials":760,"activeCount":60},[],{"trials":762,"activeCount":60},[],{"trials":764,"activeCount":60},[],{"intervention":740,"totalTrials":56,"cells":766},{"EARLY_PHASE1":767,"PHASE1":769,"PHASE2":771,"PHASE3":777,"PHASE4":779,"NA":781},{"trials":768,"activeCount":60},[],{"trials":770,"activeCount":60},[],{"trials":772,"activeCount":60},[773],{"nctId":731,"briefTitle":732,"status":373,"phases":774,"start":734,"enrollment":735,"conditions":775,"interventions":776},[50],[737],[722,739,740],{"trials":778,"activeCount":60},[],{"trials":780,"activeCount":60},[],{"trials":782,"activeCount":60},[],{"intervention":784,"totalTrials":31,"cells":785},"Propofol",{"EARLY_PHASE1":786,"PHASE1":788,"PHASE2":790,"PHASE3":792,"PHASE4":794,"NA":796},{"trials":787,"activeCount":60},[],{"trials":789,"activeCount":60},[],{"trials":791,"activeCount":60},[],{"trials":793,"activeCount":60},[],{"trials":795,"activeCount":60},[],{"trials":797,"activeCount":60},[798,810,823],{"nctId":799,"briefTitle":800,"status":164,"phases":801,"primaryCompletion":802,"completion":802,"start":803,"enrollment":804,"conditions":805,"interventions":809},"NCT02046590","RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP",[53],"2023-02-13","2014-02",120,[15,806,807,808],"ERCP","Safety","Efficacy",[784],{"nctId":811,"briefTitle":812,"status":175,"phases":813,"primaryCompletion":814,"completion":815,"start":816,"enrollment":817,"conditions":818,"interventions":820},"NCT05944887","Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.",[53],"2023-08-21","2023-08-25","2023-07-21",46,[819],"Diagnostic Gastroscopy",[821,822,784],"Lidocaine 2% Injectable Solution","Saline administration as placebo",{"nctId":824,"briefTitle":825,"status":373,"phases":826,"primaryCompletion":827,"completion":827,"start":828,"enrollment":378,"conditions":829,"interventions":830},"NCT06143410","Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy",[53],"2024-08-31","2024-04-08",[819],[821,822,784],{"intervention":435,"totalTrials":149,"cells":832},{"EARLY_PHASE1":833,"PHASE1":835,"PHASE2":837,"PHASE3":839,"PHASE4":845,"NA":847},{"trials":834,"activeCount":60},[],{"trials":836,"activeCount":60},[],{"trials":838,"activeCount":60},[],{"trials":840,"activeCount":60},[841],{"nctId":422,"briefTitle":423,"status":373,"phases":842,"primaryCompletion":425,"completion":426,"start":427,"enrollment":428,"conditions":843,"interventions":844},[50,51],[430,431,432,433],[411,435],{"trials":846,"activeCount":60},[],{"trials":848,"activeCount":60},[849],{"nctId":850,"briefTitle":851,"status":175,"phases":852,"primaryCompletion":853,"completion":854,"start":855,"enrollment":856,"conditions":857,"interventions":862},"NCT03395977","Uric Acid Effects on Endothelium and Oxydative Stress",[53],"2019-12-31","2020-02-27","2018-01-03",53,[858,859,860,861],"Oxidative Stress","Endothelial Function","Cardiovascular System","Hypertension",[435,863,864],"Febuxostat","Rasburicase",{"intervention":821,"totalTrials":149,"cells":866},{"EARLY_PHASE1":867,"PHASE1":869,"PHASE2":871,"PHASE3":873,"PHASE4":875,"NA":877},{"trials":868,"activeCount":60},[],{"trials":870,"activeCount":60},[],{"trials":872,"activeCount":60},[],{"trials":874,"activeCount":60},[],{"trials":876,"activeCount":60},[],{"trials":878,"activeCount":60},[879,883],{"nctId":811,"briefTitle":812,"status":175,"phases":880,"primaryCompletion":814,"completion":815,"start":816,"enrollment":817,"conditions":881,"interventions":882},[53],[819],[821,822,784],{"nctId":824,"briefTitle":825,"status":373,"phases":884,"primaryCompletion":827,"completion":827,"start":828,"enrollment":378,"conditions":885,"interventions":886},[53],[819],[821,822,784],{"intervention":822,"totalTrials":149,"cells":888},{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":893,"PHASE3":895,"PHASE4":897,"NA":899},{"trials":890,"activeCount":60},[],{"trials":892,"activeCount":60},[],{"trials":894,"activeCount":60},[],{"trials":896,"activeCount":60},[],{"trials":898,"activeCount":60},[],{"trials":900,"activeCount":60},[901,905],{"nctId":811,"briefTitle":812,"status":175,"phases":902,"primaryCompletion":814,"completion":815,"start":816,"enrollment":817,"conditions":903,"interventions":904},[53],[819],[821,822,784],{"nctId":824,"briefTitle":825,"status":373,"phases":906,"primaryCompletion":827,"completion":827,"start":828,"enrollment":378,"conditions":907,"interventions":908},[53],[819],[821,822,784],{"intervention":910,"totalTrials":149,"cells":911},"Remifentanil",{"EARLY_PHASE1":912,"PHASE1":914,"PHASE2":916,"PHASE3":918,"PHASE4":920,"NA":922},{"trials":913,"activeCount":60},[],{"trials":915,"activeCount":60},[],{"trials":917,"activeCount":60},[],{"trials":919,"activeCount":60},[],{"trials":921,"activeCount":60},[],{"trials":923,"activeCount":60},[924,937],{"nctId":925,"briefTitle":926,"status":373,"phases":927,"primaryCompletion":928,"completion":928,"start":929,"enrollment":253,"conditions":930,"interventions":934},"NCT03458143","Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval",[],"2018-03-31","2018-02-12",[931,932,933],"Oocyte Retrieval","Sedation, Conscious","Ventilatory Depression",[935,910,936],"Ketamine 150 ng\u002Fml","Ketamine 200 ng\u002Fml",{"nctId":938,"briefTitle":939,"status":175,"phases":940,"primaryCompletion":853,"completion":853,"start":941,"enrollment":942,"conditions":943,"interventions":947},"NCT03912740","Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia",[53],"2019-04-11",58,[944,15,945,946],"Nociceptive Pain","Opioid Use","Perioperative\u002FPostoperative Complications",[383,948,910],"sodium chloride",{"intervention":383,"totalTrials":149,"cells":950},{"EARLY_PHASE1":951,"PHASE1":953,"PHASE2":955,"PHASE3":957,"PHASE4":959,"NA":965},{"trials":952,"activeCount":60},[],{"trials":954,"activeCount":60},[],{"trials":956,"activeCount":60},[],{"trials":958,"activeCount":60},[],{"trials":960,"activeCount":60},[961],{"nctId":371,"briefTitle":372,"status":373,"phases":962,"primaryCompletion":375,"completion":376,"start":377,"enrollment":378,"conditions":963,"interventions":964},[52],[380,381],[358,383],{"trials":966,"activeCount":60},[967],{"nctId":938,"briefTitle":939,"status":175,"phases":968,"primaryCompletion":853,"completion":853,"start":941,"enrollment":942,"conditions":969,"interventions":970},[53],[944,15,945,946],[383,948,910],{"intervention":972,"totalTrials":56,"cells":973},"Insulin",{"EARLY_PHASE1":974,"PHASE1":976,"PHASE2":978,"PHASE3":980,"PHASE4":982,"NA":984},{"trials":975,"activeCount":60},[],{"trials":977,"activeCount":60},[],{"trials":979,"activeCount":60},[],{"trials":981,"activeCount":60},[],{"trials":983,"activeCount":60},[],{"trials":985,"activeCount":60},[986],{"nctId":987,"briefTitle":988,"status":989,"phases":990,"primaryCompletion":991,"completion":992,"start":993,"enrollment":60,"conditions":994,"interventions":997},"NCT06391853","Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study","WITHDRAWN",[53],"2026-03-01","2026-10-01","2024-10-01",[995,996],"Alzheimer Disease","Mild Cognitive Impairment",[972],{"intervention":999,"totalTrials":56,"cells":1000},"Methylprednisolone or placebo",{"EARLY_PHASE1":1001,"PHASE1":1003,"PHASE2":1005,"PHASE3":1007,"PHASE4":1009,"NA":1011},{"trials":1002,"activeCount":60},[],{"trials":1004,"activeCount":60},[],{"trials":1006,"activeCount":60},[],{"trials":1008,"activeCount":60},[],{"trials":1010,"activeCount":60},[],{"trials":1012,"activeCount":60},[1013],{"nctId":1014,"briefTitle":1015,"status":373,"phases":1016,"primaryCompletion":1017,"completion":1018,"start":1019,"enrollment":1020,"conditions":1021,"interventions":1022},"NCT03160651","Corticosteroids in Alcoholic Hepatitis",[53],"2022-06","2022-12","2018-02-09",140,[506],[999],{"intervention":1024,"totalTrials":56,"cells":1025},"induction by Etomidate bolus",{"EARLY_PHASE1":1026,"PHASE1":1028,"PHASE2":1030,"PHASE3":1032,"PHASE4":1034,"NA":1036},{"trials":1027,"activeCount":60},[],{"trials":1029,"activeCount":60},[],{"trials":1031,"activeCount":60},[],{"trials":1033,"activeCount":60},[],{"trials":1035,"activeCount":60},[],{"trials":1037,"activeCount":60},[1038],{"nctId":1039,"briefTitle":1040,"status":175,"phases":1041,"primaryCompletion":1042,"completion":1042,"start":1043,"enrollment":1044,"conditions":1045,"interventions":1046},"NCT05862753","Duration and Depth of Anesthesia Induced by a Bolus of Etomidate",[53],"2022-04-20","2022-01-11",18,[15],[1024],{"intervention":1048,"totalTrials":56,"cells":1049},"Nitrous oxide for labour analgesia",{"EARLY_PHASE1":1050,"PHASE1":1052,"PHASE2":1054,"PHASE3":1056,"PHASE4":1058,"NA":1060},{"trials":1051,"activeCount":60},[],{"trials":1053,"activeCount":60},[],{"trials":1055,"activeCount":60},[],{"trials":1057,"activeCount":60},[],{"trials":1059,"activeCount":60},[],{"trials":1061,"activeCount":60},[1062],{"nctId":1063,"briefTitle":1064,"status":175,"phases":1065,"primaryCompletion":1066,"completion":1067,"start":1068,"enrollment":1069,"conditions":1070,"interventions":1073},"NCT06595303","Nitrous Oxyde During Labour",[],"2025-05-15","2025-05-20","2024-11-05",70,[1071,1072],"Nitrous Oxide","Labour Analgesia",[1048],{"intervention":1075,"totalTrials":56,"cells":1076},"Vitamin C",{"EARLY_PHASE1":1077,"PHASE1":1079,"PHASE2":1081,"PHASE3":1083,"PHASE4":1085,"NA":1087},{"trials":1078,"activeCount":60},[],{"trials":1080,"activeCount":60},[],{"trials":1082,"activeCount":60},[],{"trials":1084,"activeCount":60},[],{"trials":1086,"activeCount":60},[],{"trials":1088,"activeCount":60},[1089],{"nctId":1090,"briefTitle":1091,"status":175,"phases":1092,"primaryCompletion":1093,"completion":1094,"start":1095,"enrollment":1096,"conditions":1097,"interventions":1102},"NCT07369232","Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT)",[53],"2026-03-31","2026-04-30","2025-09-01",13,[1098,1099,1100,1101,858],"Oxygen","Hyperoxemia","Antioxidant","Cerebral Autoregulation",[1075],{"intervention":1104,"totalTrials":56,"cells":1105},"Propofol-remifentanil sedation",{"EARLY_PHASE1":1106,"PHASE1":1108,"PHASE2":1110,"PHASE3":1112,"PHASE4":1114,"NA":1116},{"trials":1107,"activeCount":60},[],{"trials":1109,"activeCount":60},[],{"trials":1111,"activeCount":60},[],{"trials":1113,"activeCount":60},[],{"trials":1115,"activeCount":60},[],{"trials":1117,"activeCount":60},[1118],{"nctId":1119,"briefTitle":1120,"status":175,"phases":1121,"primaryCompletion":1122,"completion":1122,"start":1123,"enrollment":280,"conditions":1124,"interventions":1128},"NCT05244538","Effectiveness of Hypnosis Via Virtual Reality During Oocyte Retrieval",[53],"2022-04-11","2022-02-01",[1125,1126,784,910,1127],"Virtual Reality Therapy","Fertilization in Vitro","Conscious Sedation",[1104],{"intervention":935,"totalTrials":56,"cells":1130},{"EARLY_PHASE1":1131,"PHASE1":1133,"PHASE2":1135,"PHASE3":1137,"PHASE4":1139,"NA":1141},{"trials":1132,"activeCount":60},[],{"trials":1134,"activeCount":60},[],{"trials":1136,"activeCount":60},[],{"trials":1138,"activeCount":60},[],{"trials":1140,"activeCount":60},[],{"trials":1142,"activeCount":60},[1143],{"nctId":925,"briefTitle":926,"status":373,"phases":1144,"primaryCompletion":928,"completion":928,"start":929,"enrollment":253,"conditions":1145,"interventions":1146},[],[931,932,933],[935,910,936],{"intervention":936,"totalTrials":56,"cells":1148},{"EARLY_PHASE1":1149,"PHASE1":1151,"PHASE2":1153,"PHASE3":1155,"PHASE4":1157,"NA":1159},{"trials":1150,"activeCount":60},[],{"trials":1152,"activeCount":60},[],{"trials":1154,"activeCount":60},[],{"trials":1156,"activeCount":60},[],{"trials":1158,"activeCount":60},[],{"trials":1160,"activeCount":60},[1161],{"nctId":925,"briefTitle":926,"status":373,"phases":1162,"primaryCompletion":928,"completion":928,"start":929,"enrollment":253,"conditions":1163,"interventions":1164},[],[931,932,933],[935,910,936],{"intervention":1166,"totalTrials":56,"cells":1167},"sickle cell syndrome",{"EARLY_PHASE1":1168,"PHASE1":1170,"PHASE2":1172,"PHASE3":1174,"PHASE4":1176,"NA":1178},{"trials":1169,"activeCount":60},[],{"trials":1171,"activeCount":60},[],{"trials":1173,"activeCount":60},[],{"trials":1175,"activeCount":60},[],{"trials":1177,"activeCount":60},[],{"trials":1179,"activeCount":60},[1180],{"nctId":1181,"briefTitle":1182,"status":373,"phases":1183,"primaryCompletion":1184,"completion":1185,"start":1186,"enrollment":1187,"conditions":1188,"interventions":1190},"NCT04205123","Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease",[],"2024-12-31","2025-01-01","2014-10-20",200,[1189],"Sickle Cell Disease",[1166],{"intervention":863,"totalTrials":56,"cells":1192},{"EARLY_PHASE1":1193,"PHASE1":1195,"PHASE2":1197,"PHASE3":1199,"PHASE4":1201,"NA":1203},{"trials":1194,"activeCount":60},[],{"trials":1196,"activeCount":60},[],{"trials":1198,"activeCount":60},[],{"trials":1200,"activeCount":60},[],{"trials":1202,"activeCount":60},[],{"trials":1204,"activeCount":60},[1205],{"nctId":850,"briefTitle":851,"status":175,"phases":1206,"primaryCompletion":853,"completion":854,"start":855,"enrollment":856,"conditions":1207,"interventions":1208},[53],[858,859,860,861],[435,863,864],{"intervention":864,"totalTrials":56,"cells":1210},{"EARLY_PHASE1":1211,"PHASE1":1213,"PHASE2":1215,"PHASE3":1217,"PHASE4":1219,"NA":1221},{"trials":1212,"activeCount":60},[],{"trials":1214,"activeCount":60},[],{"trials":1216,"activeCount":60},[],{"trials":1218,"activeCount":60},[],{"trials":1220,"activeCount":60},[],{"trials":1222,"activeCount":60},[1223],{"nctId":850,"briefTitle":851,"status":175,"phases":1224,"primaryCompletion":853,"completion":854,"start":855,"enrollment":856,"conditions":1225,"interventions":1226},[53],[858,859,860,861],[435,863,864],{"intervention":1228,"totalTrials":56,"cells":1229},"Neuromuscular Blocking Agent",{"EARLY_PHASE1":1230,"PHASE1":1232,"PHASE2":1234,"PHASE3":1236,"PHASE4":1238,"NA":1240},{"trials":1231,"activeCount":60},[],{"trials":1233,"activeCount":60},[],{"trials":1235,"activeCount":60},[],{"trials":1237,"activeCount":60},[],{"trials":1239,"activeCount":60},[],{"trials":1241,"activeCount":60},[1242],{"nctId":1243,"briefTitle":1244,"status":373,"phases":1245,"primaryCompletion":1246,"completion":1184,"start":1247,"enrollment":1248,"conditions":1249,"interventions":1252},"NCT06238219","Management of Neuromuscular Blocking Agents and Their Antagonism",[],"2024-11-30","2024-04-17",3000,[1250,1251],"Neuromuscular Blocking Agents","Neuromuscular Monitoring",[1228],{"intervention":1254,"totalTrials":56,"cells":1255},"Lidocain",{"EARLY_PHASE1":1256,"PHASE1":1258,"PHASE2":1260,"PHASE3":1262,"PHASE4":1264,"NA":1266},{"trials":1257,"activeCount":60},[],{"trials":1259,"activeCount":60},[],{"trials":1261,"activeCount":60},[],{"trials":1263,"activeCount":60},[],{"trials":1265,"activeCount":60},[],{"trials":1267,"activeCount":60},[1268],{"nctId":1269,"briefTitle":1270,"status":373,"phases":1271,"primaryCompletion":1272,"completion":1272,"start":1273,"enrollment":324,"conditions":1274,"interventions":1277},"NCT05930236","Ultrasound-guided LMBB by Caudal-cranial Approach: Radiographic Comparison of a New Ultrasound-guided Method",[53],"2024-06","2023-04-21",[1275,1276],"Chronic Low-back Pain","Lumbar Facet Joint Syndrome",[1254,1278,1279],"Methylprednisolone","Omnipaque",{"intervention":1278,"totalTrials":56,"cells":1281},{"EARLY_PHASE1":1282,"PHASE1":1284,"PHASE2":1286,"PHASE3":1288,"PHASE4":1290,"NA":1292},{"trials":1283,"activeCount":60},[],{"trials":1285,"activeCount":60},[],{"trials":1287,"activeCount":60},[],{"trials":1289,"activeCount":60},[],{"trials":1291,"activeCount":60},[],{"trials":1293,"activeCount":60},[1294],{"nctId":1269,"briefTitle":1270,"status":373,"phases":1295,"primaryCompletion":1272,"completion":1272,"start":1273,"enrollment":324,"conditions":1296,"interventions":1297},[53],[1275,1276],[1254,1278,1279],{"intervention":1279,"totalTrials":56,"cells":1299},{"EARLY_PHASE1":1300,"PHASE1":1302,"PHASE2":1304,"PHASE3":1306,"PHASE4":1308,"NA":1310},{"trials":1301,"activeCount":60},[],{"trials":1303,"activeCount":60},[],{"trials":1305,"activeCount":60},[],{"trials":1307,"activeCount":60},[],{"trials":1309,"activeCount":60},[],{"trials":1311,"activeCount":60},[1312],{"nctId":1269,"briefTitle":1270,"status":373,"phases":1313,"primaryCompletion":1272,"completion":1272,"start":1273,"enrollment":324,"conditions":1314,"interventions":1315},[53],[1275,1276],[1254,1278,1279],{"intervention":948,"totalTrials":56,"cells":1317},{"EARLY_PHASE1":1318,"PHASE1":1320,"PHASE2":1322,"PHASE3":1324,"PHASE4":1326,"NA":1328},{"trials":1319,"activeCount":60},[],{"trials":1321,"activeCount":60},[],{"trials":1323,"activeCount":60},[],{"trials":1325,"activeCount":60},[],{"trials":1327,"activeCount":60},[],{"trials":1329,"activeCount":60},[1330],{"nctId":938,"briefTitle":939,"status":175,"phases":1331,"primaryCompletion":853,"completion":853,"start":941,"enrollment":942,"conditions":1332,"interventions":1333},[53],[944,15,945,946],[383,948,910],{"intervention":1335,"totalTrials":56,"cells":1336},"Incretinomimetics",{"EARLY_PHASE1":1337,"PHASE1":1339,"PHASE2":1341,"PHASE3":1343,"PHASE4":1345,"NA":1347},{"trials":1338,"activeCount":60},[],{"trials":1340,"activeCount":60},[],{"trials":1342,"activeCount":60},[],{"trials":1344,"activeCount":60},[],{"trials":1346,"activeCount":60},[],{"trials":1348,"activeCount":60},[1349],{"nctId":1350,"briefTitle":1351,"status":164,"phases":1352,"primaryCompletion":802,"completion":802,"start":1353,"enrollment":9,"conditions":1354,"interventions":1357},"NCT02244164","Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.",[53],"2014-10",[1355,1335,1356],"Type 2 Diabetes","Pancreas",[1335,1358],"DPP-4 inhibitors",{"intervention":1358,"totalTrials":56,"cells":1360},{"EARLY_PHASE1":1361,"PHASE1":1363,"PHASE2":1365,"PHASE3":1367,"PHASE4":1369,"NA":1371},{"trials":1362,"activeCount":60},[],{"trials":1364,"activeCount":60},[],{"trials":1366,"activeCount":60},[],{"trials":1368,"activeCount":60},[],{"trials":1370,"activeCount":60},[],{"trials":1372,"activeCount":60},[1373],{"nctId":1350,"briefTitle":1351,"status":164,"phases":1374,"primaryCompletion":802,"completion":802,"start":1353,"enrollment":9,"conditions":1375,"interventions":1376},[53],[1355,1335,1356],[1335,1358],{"intervention":1378,"totalTrials":56,"cells":1379},"Use of tranexamic acid",{"EARLY_PHASE1":1380,"PHASE1":1382,"PHASE2":1384,"PHASE3":1386,"PHASE4":1388,"NA":1390},{"trials":1381,"activeCount":60},[],{"trials":1383,"activeCount":60},[],{"trials":1385,"activeCount":60},[],{"trials":1387,"activeCount":60},[],{"trials":1389,"activeCount":60},[],{"trials":1391,"activeCount":60},[1392],{"nctId":1393,"briefTitle":1394,"status":175,"phases":1395,"primaryCompletion":815,"completion":1396,"start":1397,"enrollment":1398,"conditions":1399,"interventions":1403},"NCT05783648","Do Anesthesiologists Follow Guidelines on Perioperative Use of Tranexamic Acid?",[],"2023-08-29","2023-07-03",1726,[1400,1401,1402],"Tranexamic Acid","Blood Loss, Surgical","Blood Transfusion",[1378],{"intervention":1405,"totalTrials":56,"cells":1406},"Trisodium citrate",{"EARLY_PHASE1":1407,"PHASE1":1409,"PHASE2":1411,"PHASE3":1413,"PHASE4":1415,"NA":1417},{"trials":1408,"activeCount":60},[],{"trials":1410,"activeCount":60},[],{"trials":1412,"activeCount":60},[],{"trials":1414,"activeCount":60},[],{"trials":1416,"activeCount":60},[],{"trials":1418,"activeCount":60},[1419],{"nctId":1420,"briefTitle":1421,"status":175,"phases":1422,"primaryCompletion":1423,"completion":1424,"start":1425,"enrollment":666,"conditions":1426,"interventions":1428},"NCT01689753","Effect of the TEGO Connector in Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and\u002For Bacteremia",[53],"2010-04","2011-03","2009-03",[1427],"Other Complication of Vascular Dialysis Catheter",[1405],{"intervention":1430,"totalTrials":56,"cells":1431},"Esketamine at low dose",{"EARLY_PHASE1":1432,"PHASE1":1434,"PHASE2":1436,"PHASE3":1438,"PHASE4":1440,"NA":1442},{"trials":1433,"activeCount":60},[],{"trials":1435,"activeCount":60},[],{"trials":1437,"activeCount":60},[],{"trials":1439,"activeCount":60},[],{"trials":1441,"activeCount":60},[],{"trials":1443,"activeCount":60},[1444],{"nctId":1445,"briefTitle":1446,"status":175,"phases":1447,"primaryCompletion":1448,"completion":1448,"start":1449,"enrollment":856,"conditions":1450,"interventions":1455},"NCT07528651","Effects of S-ketamine on Perioperative Opioid Consumption",[53],"2022-06-21","2021-06-07",[1451,1452,1453,1454],"Pain Management","Postoperative Pain","Opioid Consumption, Postoperative","Opioid Analgesia",[1430,1456],"Saline",{"intervention":1456,"totalTrials":56,"cells":1458},{"EARLY_PHASE1":1459,"PHASE1":1461,"PHASE2":1463,"PHASE3":1465,"PHASE4":1467,"NA":1469},{"trials":1460,"activeCount":60},[],{"trials":1462,"activeCount":60},[],{"trials":1464,"activeCount":60},[],{"trials":1466,"activeCount":60},[],{"trials":1468,"activeCount":60},[],{"trials":1470,"activeCount":60},[1471],{"nctId":1445,"briefTitle":1446,"status":175,"phases":1472,"primaryCompletion":1448,"completion":1448,"start":1449,"enrollment":856,"conditions":1473,"interventions":1474},[53],[1451,1452,1453,1454],[1430,1456]]